1.	Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls Phase: Phase IV Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 13 to 15 at first immunization Sponsor: Other Protocol IDs: HPV CSP01, NCT00956553
2.	Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China Phase: Phase IV Type: Prevention Status: Approved-not yet active Age: 13 to 15 Sponsor: Other Protocol IDs: 37207, NCT01021904
3.	Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females Phase: Phase IV Type: Prevention Status: Active Age: 15 to 25 Sponsor: Pharmaceutical / Industry Protocol IDs: 109823, NCT01031069
4.	Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? Phase: Phase IV Type: Prevention Status: Active Age: 11 to 17 Sponsor: Other Protocol IDs: GardasilMerckGomez-Lobo, NCT01101750
5.	A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 19 and over Sponsor: Other Protocol IDs: Oral Zinc RTC, H11-01758, NCT01468636
6.	Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CBKM120ZBR01, NCT01613677
7.	Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study Phase: Phase IV Type: Prevention Status: Approved-not yet active Age: 18 to 26 Sponsor: Other Protocol IDs: CIHR-MOP-125949, IIS #38265, NCT01824537
8.	Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: INTERTECC, R21CA162718-01, NCT01554397
9.	Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: EORTC-55994, 2008-003396-52, NCT00039338
10.	Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: E33022, NCT00122746
11.	18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology Phase: Phase III Type: Diagnostic Status: Active Age: 19 to 90 Sponsor: Other Protocol IDs: R05-0076, NCT00207298
12.	Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 119 of 2003, NCT00193739
13.	Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: TMH/114/2003/CRACX TRIAL, NCT00193791
14.	Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00591, GOG-0219, CAN-NCIC-GOG-0219, CDR0000455555, U10CA027469, NCT00262821
15.	Diindolylmethane in Treating Patients With Abnormal Cervical Cells. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Prevention Status: Active Age: Not specified Sponsor: Other Protocol IDs: CRUK-CRISP-1, ISRCTN47437431, EU-20717, NCT00462813
16.	Prospective Randomized Open Label Study of the Treatment of Therapy-Associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium - Phase: Phase III Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093
17.	Hydralazine Valproate for Cervical Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 006/027/ICI, NCT00532818
18.	Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 21 and over Sponsor: Other Protocol IDs: Cervix Cancer Research, NCT00548821
19.	Laparoscopic Approach to Cervical Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LACC001, NCT00614211
20.	Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VRAM M-20070240, NCT00647569
21.	The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 0014-08-RMC, NCT00726635
22.	A Multicenter Trial of Benefits of Adding Post-surgery Chemotherapy for Cervical Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 2008049, NCT00806117
23.	A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 25387, 1 R01 HL95109-01, NCT00876915
24.	Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects Phase: Phase III Type: Screening Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 112024, NCT00937950
25.	Study Comparing Isolated Pelvic Perfusion With TNF-a 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 to 76 Sponsor: Other Protocol IDs: PIP2, CSET 1443, NCT00949039